Replating potential of colony-forming units of granulocytes/macrophages (CFE-GM) expanded ex vivo by stem cell factor, interleukin (IL)-3, IL-6, granulocyte colony-stimulating factor, erythropoietin with or without thrombopoietin
スポンサーリンク
概要
著者
-
Yamamoto Katsuya
Hematology/oncology Department Of Medicine Kobe University Graduate School Of Medicine
-
Katayama Y
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Katayama Yoshio
神戸大学 医学研究科血液内科学
-
TESHIMA Takanori
Center for Cellular and Molecular Medicine, Kyushu University Hospital
-
Harada Mine
Department Of Medicine And Biosystemic Science Kyushu University Graduate School Of Medical Sciences
-
Harada Mine
岡山大学 第2内科
-
Shimoda Kazuya
九州大学 医学部病態情報学
-
KATAYAMA Yoshio
Second Department of Medicine, Okayama University Medical School
-
SHINAGAWA Katsuji
Second Department of Medicine, Okayama University Medical School
-
OMOTO Eijiro
Second Department of Medicine, Okayama University Medical School
-
HARADA Mine
Second Department of Medicine, Okayama University Medical School
-
TAKENAKA Katsuto
Second Department of Internal Medicine, Okayama University Medical School
-
MAHMUT Naira
Second Department of Internal Medicine, Okayama University Medical School
-
TESHIMA Takanori
Second Department of Internal Medicine, Okayama University Medical School
-
Hamaguchi Motohiro
Department Of Hematology Clinical And Research Center National Hospital Organization Nagoya Medical
-
Shinagawa K
Okayama Univ. Hospital Okayama Jpn
-
Teshima T
Center For Cellular And Molecular Medicine Kyushu University Hospital
-
Harada Mine
Second Department Of Internal Medicine Okayama University Medical School
-
Shigeno Kazuyuki
Japan Adult Leukemia Study Group Hamamatsu Jpn
-
Hidaka Michihiro
Department Of Internal Medicine Kumamoto Medical Center National Hospital Organization
-
Sunami K
Department Of Hematology National Hospital Organization Okayama Medical Center
-
Sunami Kazutaka
Division Of Hematology Department Of Internal Medicine National Hospital Organization Okayama Medica
-
Katayama Yoshio
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Shinagawa Katsushi
The Second Department Of Internal Medicine
-
Shinagawa Katsuji
Department Of Biopathological Science Okayama University Graduate School Of Medicine And Dentistry
-
Shinagawa Katsuji
Division Of Hematology/oncology Okayama University Medical School
-
Katayama Yoshio
Hematology/oncology Department Of Medicine Kobe University Graduate School Of Medicine
-
Teshima Takanori
Department Of Biopathological Science Okayama University Graduate School Of Medicine And Dentistry
-
Mahmut Naira
Second Department Of Internal Medicine Okayama University Medical School
-
Omoto E
Okayama Univ. Medical School Okayama Jpn
-
Omoto Eijiro
Second Department Of Medicine Okayama University Medical School
-
Harada Mine
Second Department Of Internal Medicine Okayama University School Of Medicine
-
Teshima Takanori
Second Department Of Internal Medicine Okayama University Medical School
-
Kawano Yuko
Division Of Hematology Department Of Medicine Kobe University Graduate School Of Medicine
-
Hara Masamichi
Department Of Internal Medicine Kumamoto Medical Center National Hospital Organization
-
Shimoda Kazuya
Medicine And Biosystemic Science Graduate School Of Medical Sciences Kyushu University
-
Yakushiji Kazuaki
Division Of Hematology Department Of Medicine Kurume University School Of Medicine
-
Katayama Yoshio
Second Department Of Internal Medicine Okayama University Medical School
-
Shinagawa Katsuji
Second Department Of Internal Medicine Okayama University Medical School
-
Hamaguchi M
Division Of Hematology Ehime Prefectural Central Hospital
関連論文
- Therapy-related Myelodysplastic/myeloproliferative Neoplasms with del(5q) and t(1;11)(p32;q23) Lacking MLL Rearrangement
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- Use of hydroxy-methyl-glutaryl coenzyme A reductase inhibitors is associated with risk of lymphoid malignancies
- Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
- Reconstitution of HLA-A^*2402-Restricted Cytomegalovirus-Specific T-Cells following Stem Cell Transplantation
- MPO-ANCA-positive Wegener's granulomatosis presenting with hypertrophic cranial pachymeningitis : case report and review of the literature
- Chronic Graft-versus-Host Disease following Varicella-Zoster Virus Infection in Allogeneic Stem Cell Transplant Recipients
- Systemic Vasculitis Associated with α1-antitrypsin Deficiency
- Molecular mechanisms of lipopolysaccharide-induced cyclooxygenase-2 expression in human neutrophils : involvement of the mitogen-activated protein kinase pathway and regulation by anti-inflammatory cytokines
- Smoking, drinking, sleeping habits, and other lifestyle factors and the risk of systemic lupus erythematosus in Japanese females : findings from the KYSS study
- Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients
- Additional acquisition of t(1;21)(p32;q22) in a patient relapsing with acute myelogenous leukemia with NUP98-HOXA9
- Successful treatment of parainfluenza virus 3 pneumonia with oral ribavirin and methylprednisolone in a bone marrow transplant recipient
- Progressive osteosclerosis and visceral calcification after cord blood transplantation
- Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies
- Pharmacokinetics-based optimal dose-exploration of mycophenolate mofetil in allogeneic hematopoietic stem cell transplantation
- Successful Treatment with Defibrotide for Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation
- Allogeneic Peripheral Blood Stem Cell Transplantation in 23 Adult Patients With Hematologic Malignancies: A Single-Center Experience
- Granulocyte Colony-Stimulating Factor and Lineage-Independent Modulation of VLA-4 Expression on Circulating CD34^+ Cells
- Replating potential of colony-forming units of granulocytes/macrophages (CFE-GM) expanded ex vivo by stem cell factor, interleukin (IL)-3, IL-6, granulocyte colony-stimulating factor, erythropoietin with or without thrombopoietin
- Trisomy 12 and t(14;18) in B-cell chronic lymphocytic leukemia
- G-CSF-induced mobilization of peripheral blood stem cells for allografting: comparative study of daily single versus divided dose of G-CSF
- Androgen therapy in combination with granulocyte colony-stimulating factor and erythropoietin in a patient with refractory anemia
- Successful engraftment in reduced-intensity cord blood transplantation (CBT) as a salvage therapy for graft failure after primary CBT in adults
- Translocation (7;9)(q22;q34) in therapy-related myelodysplastic syndrome after allogeneic bone marrow transplantation for acute myeloblastic leukemia
- A novel t(8;18)(q13;q21) in acute monocytic leukemia evolving from constitutional trisomy 8 mosaicism
- Derivative (3)t(3;18)(q27;q21)t(18;16)(q21;?) involving the BCL2 and BCL6 genes in follicular lymphoma with t(3;14;18) (q27; q32; q21)
- A multicenter analysis of the FIP1L1-αPDGFR fusion gene in Japanese idiopathic hypereosinophilic syndrome: an aberrant splicing skipping the αPDGFR exon 12
- Imatinib resistance in a novel translocation der(17)t(1;17)(q25;p13) with loss of TP53 but without BCR/ABL kinase domain mutation in chronic myelogenous leukemia
- Unbalanced whole-arm translocation der(5;19)(p10;q10) is a novel and recurrent cytogenetic aberration in myelodysplastic syndrome
- Chronic myeloid leukemia with a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2)
- Rapid hematopoietic progenitor mobilization by sulfated colominic acid
- Predominant Infiltration of Monocytes in Chronic Graft-Versus-Host Disease
- Pure red cell aplasia with primary sclerosing cholangitis
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- The effect of adding rituximab to CHOP-based therapy on clinical outcomes for Japanese patients with diffuse large B-cell lymphoma : a propensity score matching analysis
- Successful Treatment of Limited Disease-Small Cell Lung Cancer with Multimodality Treatment Consisting of Concurrent Chemoradiotherapy, High-Dose Chemotherapy with Autologous Peripheral Blood Stem Cell Transplantation and Surgical Resection
- Dock2 participates in bone marrow lympho-hematopoiesis
- Two Novel Gene Mutations in Type I Antithrombin Deficiency
- Current Status of Hematopoietic Cell Transplantation for Adult Patients with Hematologic Diseases and Solid Tumors in Japan
- Successful Engraftment of Allogeneic Peripheral Blood Stem Cell Transplant After Nonmyeloablative Preparative Regimen With Cytarabine and Cyclophosphamide: Report of 2 Cases
- Molecular characterization of total kininogen deficiency in Japanese patients
- Analysis of circulating hematopoietic progenitor cells after peripheral blood stem cell transplantation
- Risk of Neutropenic Fever and Early Infectious Complications after Autologous Peripheral Blood Stem Cell Transplantation for Malignant Diseases
- Successful Treatment of Progressive NK Cell Lymphoma with Allogeneic Peripheral Stem Cell Transplantation Followed by Early Cyclosporine Tapering and Donor Leukocyte Infusions
- Ocular Manifestation of Acute Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation
- Severe Bleeding Tendency Caused by Leukemic Infiltration and Destruction of Vascular Walls in Chronic Neutrophilic Leukemia
- Transient Factor VIII Inhibitor in a Hemophilia Patient After Staphylococcal Septic Shock Syndrome
- Very Young Patient with Peculiar Squamous Cell Carcinoma of the Lung
- Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
- Phase I/II study of tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation for advanced multiple myeloma
- Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation
- Calcineurin Inhibitor-Induced Irreversible Neuropathic Pain after Allogeneic Hematopoietic Stem Cell Transplantation
- Myositis as a Manifestation of Chronic Graft-Versus-Host Disease
- Allogeneic Peripheral Blood Stem Cell Transplantation for the Treatment of Refractory Follicular Lymphoma
- Treatment of Refractory Metastatic Choriocarcinoma with Tandem High-Dose Chemotherapy Supported by Peripheral Blood Stem Cell Transplantation : A Case Report
- Graft rejection and recovery of host-derived hematopoiesis after allogeneic bone marrow transplantation : relation to conditioning with high does etoposide and total body irradiation
- Association of IgG Fc receptor II with tyrosine kinases in the human basophilic leukemia cell line KU812F
- Low-dose exogenous interleukin (IL)-12 enhances antigen-induced interferon-γ production without affecting IL-10 production in asthmatics
- Granulocyte colony-stimulating factor-combined marrow-ablative chemotherapy and autologous blood cell transplantation for the treatment of patients with acute myelogenous leukemia in first remission
- Arrhythmogenic and Inotropic Effects of Interferon Investigated in Perfused and in Vivo Rat Hearts : Influences of Cardiac Hypertrophy and Isoproterenol
- Double High-dose Chemotherapy Supported by Autologous Transplantation of Peripheral Blood Stem Cells for Treatment of an Elderly Patient with Small-Cell Lung Cancer
- Metastasis to the Iris in Squamous Cell Lung Cancer
- High-Dose Etoposide Treatment for CNS Involvement in a Patient with Primary Non-Hodgkin's Lymphoma of the Breast
- Successful treatment of refractory advanced nasal NK/T cell lymphoma with unrelated cord blood stem cell transplantation incorporating focal irradiation
- Second unrelated cord blood transplantation using a reduced-intensity conditioning regimen combined with gemtuzumab ozogamicin in patients with relapsed acute myelogenous leukemia
- Successful Treatment of Primary Cardiac Lymphoma by Rituximab-CHOP and High-Dose Chemotherapy with Autologous Peripheral Blood Stem Cell Transplantation
- Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease
- Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia : a single-center analysis of 47 patients
- Autoimmune hemolytic anemia in allergic granulomatous angitis (Churg-Strauss syndrome)
- Unbalanced translocation der(11)t(11;12)(q23;q13): a new recurrent cytogenetic aberration in myelodysplastic syndrome with a complex karyotype
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Histiocytic sarcoma with two immunohistopathologically distinct populations
- A novel unbalanced whole-arm translocation der(3;10)(q10;q10) in acute monocytic leukemia
- Therapy-related, mixed phenotype acute leukemia with t(1;21)(p36;q22) and RUNX1 rearrangement
- Two further cases of myelodysplastic syndrome and acute myeloid leukemia with der(5;19)(p10;q10): association with abnormalities involving chromosomes 12 and 21
- Unbalanced whole-arm translocation der(18;21)(q10;q10) is a recurrent cytogenetic aberration appearing during progression in myeloid leukemias
- Contrast-enhanced endoscopic ultrasonography (CE-EUS) findings in adrenal metastasis from renal cell carcinoma
- Phase I study of LY2469298, an Fc-engineered humanized anti-CD20 antibody, in patients with relapsed or refractory follicular lymphoma
- Detection of HTLV-1 by means of HBZ gene in situ hybridization in formalin-fixed and paraffin-embedded tissues
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- ABO blood group alleles and the risk of pancreatic cancer in a Japanese population
- Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma
- High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan
- Pharmacokinetics-based optimal dose prediction of donor source-dependent response to mycophenolate mofetil in unrelated hematopoietic cell transplantation
- Successful neutrophil engraftment by reduced use of granulocyte colony-stimulating factor after allogeneic hematopoietic stem cell transplantation with mycophenolate mofetil for graft-versus-host disease prophylaxis
- Association between insulin-like growth factor-1 polymorphisms and stomach cancer risk in a Japanese population
- M2 Macrophage/Microglial Cells Induce Activation of Stat3 in Primary Central Nervous System Lymphoma
- Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Successful treatment by donor lymphocyte infusion of adult T-cell leukemia/lymphoma relapse following allogeneic hematopoietic stem cell transplantation
- Mycophenolate mofetil : fully utilizing its benefits for GvHD prophylaxis
- Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low-and low-intermediate risk, aggressive non-Hodgkin's lymphoma : final results of the Japan Clinical Oncology Group Study, JCOG95
- Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients